Table 1 Patient’s characteristics and clinical information
From: Inguinal endometriosis: a case series and review of the literature
N | Age | BMI | Parity | Groin mass or pain | Dysmenorrhea (VAS*) | Dyspareunia (VAS) | Pelvic pain (VAS) | Catamenial Symptom | CA-125* | History / previous ENM* Diagnosis | Medical treatment | Primary diagnosis | Imaging #Enzian classification | IEM* site | Surgical #Enzian classification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Follow-up (months) | ||||||||||||||
1 | 31 | 27.7 | G1P1* | +  | 10 | 8 | 10 | − | − | C-section*, appendectomy, and inguinal herniorrhaphy (1.2)/+  | Progestin* GnRH agonist* | IEM*, adenomyosis | #Enzian(u) O0/0, T2/0, B1/1, FA | Proximal / right RL* | P0, O0/0, T0/0, B0/0, F(RL) |
Size Pain | – | ||||||||||||||
2 | 30 | 20.7 | N* | +  | 10 | 7 | 8 | +  | 68.33 | −/+  | OCP* | IEM | #Enzian(u) O0/0, T0/0, F(inguinal canal) #Enzian(m) O0/0, T0/0, F(inguinal canal) | Distal/ right RL Closure to labia majora with Scarpa facia involvement | P1, O0/0, T0/0, B0/0, F(RL) |
Size Pain | – | ||||||||||||||
3 | 35 | 33.3 | N | − | 5 | 5 | 5 | − | − | IVF*, PI*/oophorectomy, ENM* surgery/+  | – | Severe PE | #Enzian(u) O0/x, T1-/x-, B2/2, C3, FA | Proximal / right RL | P2, O1/0, T1/1, B3/2, F(RL) |
16 | |||||||||||||||
4 | 41 | 17.5 | N | +  | 4 | − | 0 | +  | 18.50 | −/+  | Progestin GnRH agonist | IEM | #Enzian(u) O0/0, T0/0, B1/1, F(inguinal canal) | Right RL | – |
Size Pain | 24 | ||||||||||||||
5 | 35 | 19.7 | N | +  | 7 | 6 | 0 | +  | 30.20 | Pilonidal sinus cystectomy/+  | Progestin | IEM, severe PE | #Enzian(u) O0/0, T2/2, B2/2, C3, FI, F (inguinal canal) | Right Adhesion to right external iliac artery and vein | P0, O0/0, T0/0, B1/1, C3, F(RL) |
Size Pain | 36 | ||||||||||||||
6* | 22 | 24.3 | N | − | 10 | − | 10 | − | − | PI/+  | Dydrogestrone* | Bilateral endometrioma | #Enzian(u) O1/2, T0/0, B0/0 | – | P3, O0/3, T1/0, B2/2, A3, FB, F(abdominal wall) |
40 | |||||||||||||||
7 | 51 | 24.1 | G3P3 | +  | 3 | 10 | 10 | +  | − | NVD*, uterus polyp/− | GnRH agonist | Left IEM | #Enzian(u) O0/0, T0/0, FA, F (left inguinal canal) | Left | – |
Size | 18 | ||||||||||||||
8 | 35 | 24.6 | G3P3 Ab1EP1* | +  | 10 | 4 | 7 | +  | 36.96 | C-section, laparotomy (7), D&C* (10) (GA* = 13W*) /+  | − | DE, IEM, endometrioma | #Enzian(u) O1/1, T2/2, B2/1, C2, FI, F (inguinal canal) | Right | – |
– | |||||||||||||||
9 | 33 | 14.2 | N | +  | 10 | − | 5 | +  | − | Inguinal herniorrhaphy (3)/− | Dienogest | IEM | #Enzian(u) O0/0, T0/0, F (inguinal canal) | Right | – |
Size | 36 |